INTRODUCTION

In cancer patients, variations in clinical outcomes are associated with the oncological characteristics of the tumor and host responses to systemic inflammation. In particular, systemic inflammatory responses in malignancies may arise from nonspecific events that are altered by neuroendocrine metabolism, these may include hematopoietic changes, endocrine hormones, and changes secondary to tumor hypoxia, necrosis, or local tissue damage [1].

The tumor microenvironment and the inflammatory response in particular play several important roles in a variety of cancer, by promoting tumor cell proliferation, survival, angiogenesis, invasion, and metastasis. This is achieved through the release of T lymphocytes, chemokines, activated cytokines, interleukin-6 (IL-6), tumor necrosis factor α, and C-reactive protein (CRP), leading to neutrophilia. Such dysregulation of the immune system and the response to hormones may alter the effect of chemotherapy [234].

Recent studies have shown that several biomarkers associated with the inflammatory response, especially CRP, the neutrophil-to-lymphocyte count ratio (NLR), and the platelet-to-lymphocyte count ratio (PLR), are predictors of a poor prognosis [3]. A high preoperative NLR is a poor prognostic marker in some cancers, including cholangiocarcinoma as well as lung, gastric, pancreatic, colorectal, and ovarian cancers [567891011], and a high preoperative PLR is associated with a poor prognosis in pancreatic and operable colorectal cancers [1112]. However, only a few studies have evaluated the significance of the NLR in thyroid cancer [1314], and, to the best of our knowledge, there has been no studies investigating the PLR in patients with papillary thyroid cancer (PTC).

In this study, we evaluated the association between the preoperative NLR and PLR and the clinicopathological characteristics of patients with PTC.

METHODS

We performed a retrospective chart review of 1,194 patients who underwent total thyroidectomy for PTC at Pusan National University Hospital between February 1, 2011 and May 31, 2013 to collect their clinical characteristics and demographic data.

Laboratory data were obtained from screening blood samples collected up to 2 weeks prior to total thyroidectomy, while thyroid-stimulating hormone (TSH) levels were measured before surgery. Complete blood counts, and automated differential counts were obtained 1 day before surgery. The NLR was calculated by dividing neutrophil count by the lymphocyte count; similarly, the PLR was calculated by dividing the platelet count by the lymphocyte count. Fasting morning blood samples were collected for these analyses.

Some earlier studies revealed that women in an immunocompromised state have higher neutrophil counts than men, probably because of sex hormones [1516]. Accordingly, we surmised that there would be a gender-based difference in neutrophil counts in some pathologic conditions such as thyroid cancer. Additionally, it has been reported that gender influences clinicopathological features that predict the prognosis of PTC [17]. Therefore, we excluded male patients from the study (n=128), and investigated the association between the preoperative NLR and PLR and the clinicopathological features of 1,066 female patients with PTC. These female patients were reassigned into quartiles based on the preoperative NLR and PLR.

A previous study showed that the combined evaluation of the NLR and PLR was superior to the evaluation of the NLR or PLR alone as a predictive factor in patients with esophageal cancer [18]. Thus, we assumed that the combination of NLR and PLR was more likely to predict poor clinicopathological factors than the NLR or PLR alone in patients with PTC.

The patients were stratified into tertile groups based on the preoperative NLR and PLR. Then the combination of NLR and PLR was calculated on the basis of data obtained value of 3rd tertile as follows: patients with both an elevated PLR (>144.07) and an elevated NLR (>1.88) were allocated a score of 2, and patients showing one or neither were allocated a score of 1 or 0, respectively.

Central compartment neck dissections were routinely performed during total thyroidectomy; selective neck dissections were performed when node metastasis was suspected by ultrasonography or computed tomography findings, or upon positive cytological findings in samples obtained by preoperative fine needle aspiration from suspicious cervical neck lymph nodes.

Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared. Tumor size was determined according to the greatest diameter of the lesion, based on postoperative biopsy results. Patients were staged according to the TNM classification system of the American Joint Committee on Cancer [19]. The T stage was classified as 1/2 or 3/4, while the N stage was classified according to lymph node metastasis (LNM) (N0 vs. N1) and lateral LNM (N0+N1a vs. N1b).

We tested for Hashimoto's thyroiditis, which was identified by diffuse lymphocyte infiltration, and lymphoid follicular formation in postoperative biopsy samples. We used the Seeplex BRAF ACE detection kit (Seegene, Seoul, Korea) to detect the BRAF V600E mutation in tumor tissues after thyroidectomy.

Informed consent was obtained from all patients, prior to thyroidectomy. The study was approved by the Institutional Review Board at Pusan National University Hospital, Busan, Korea.

Statistical analysis

Statistical analyses were performed using SPSS version 21.0 (IBM Co., Armonk, NY, USA). The Student t test was used to evaluate the relationship between the preoperative NLR and PLR and the other clinicopathological characteristics of PTC. One-way analysis of variance and Pearson chi-square test were used to compare different quartiles. Among the continuous variables, NLR, PLR, TSH, and tumor size are expressed as the median and interquartile range (IQR) age, BMI, and the number of tumors are expressed as mean±standard deviation. A P<0.05 was considered statistically significant.

RESULTS

A total of 1,066 female PTC patients were included in this analysis. Table 1 shows the relationships between the preoperative NLR and PLR values, and the clinicopathological characteristics of PTC. The preoperative NLR and PLR were significantly lower in patients aged ≥45 years and in patients with Hashimoto's thyroiditis. The PLR was significantly higher in patients with tumor size >1 cm; the median PLR was 139.89, with an IQR of 129.17 (vs. 132.41 with an IQR of 124.41 in patients with tumor size ≤1 cm; P=0.021). The preoperative NLR and PLR were not associated with multifocality, extrathyroidal extension (ETE), lateral LNM, lymphovascular invasion (LVI), the BRAF V600E mutation, tumor size, T stage, or LNM.

Patients were stratified by quartiles according to the preoperative NLR and PLR, and the prevalence of prognostic factors was compared between preoperative NLR and PLR quartiles (Tables 2, 3). Table 2 shows the relationships between clinicopathologic factors and NLR quartiles. The older patients had significant lower LNR values, but the differences were only between quartile 1 and quartile 3 and 4 in post hoc analysis. Significant differences were found between the NLR and LVI (P=0.006), but, there was not a meaningful correlation between NLR and LVI.

Table 3 showed that increasing preoperative PLR values from quartile 1 to quartile 3 were associated with increasing incidences of lateral LNM (P=0.018), with a positive correlation between the preoperative PLR from quartile 1 to quartile 3 (r=0.032, P=0.003, data not shown) and lateral LNM. However, patients in quartile 4 had a lower incidence of lateral LNM than patients in quartile 2 and 3. The older patients had significant lower PLR values, but the differences were significant only between quartile 1 and quartile 2, 3, and 4 in post hoc analysis. The preoperative PLR were not significantly associated with other clinicopathological factors (e.g., BMI, tumor size, TSH, T stage, LNM, multifocality, ETE, LVI, and the BRAF V600E mutation).

The higher value of combination of preoperative NLR and PLR were significantly associated with younger age in one way analysis of variance (P=0.004), but the differences were significant only between the score 0 and the score 2 (Table 4). There are no correlation between the combination of preoperative NLR and PLR and other prognostic factors (e.g., BMI, tumor size, TSH, T stage, LNM, lateral LNM, multifocality, ETE, LVI, and the BRAF V600E mutation).

DISCUSSION

Systemic inflammation has been reported to contribute to cancer development and progression, through the promotion of proliferation, survival, migration, and angiogenesis, as well as the suppression of antitumor immunity through the release of chemokines, especially regulatory T cells [2021].

The mechanism underlying the association of a high NLR with a poor cancer prognosis remains unknown. Cancers have been shown to secrete myeloid growth factors, such as granulocyte colony-stimulating factor, IL-1, IL-6, and tumor necrosis factor-alpha, which may result in tumor-related leukocytosis and neutrophilia [12]. Accordingly, neutrophils promote cancer progression and stimulate the tumor microenvironment by releasing tumor growth promoting factors, such as vascular endothelial growth factor [2223], hepatocyte growth factor [24], IL-6 [25], IL-8 [26], matrix metalloproteinases [27], and elastases [28].

The exact mechanisms underlying the association between an elevated PLR values and the biological behavior of cancer cells remain unclear. One hypothesis is that megakaryocyte-mediated thrombocytosis may result from the release of proinflammatory mediators such as IL-1, IL-2, and IL-6 [29]. Moreover, a high PLR value may be considered an indicator of inflammation [20].

Several studies have reported that a high NLR may be associated with a poor prognosis of solid tumor cancers, including lung, gastric, pancreatic, ovarian, and colorectal cancers, in addition to colorectal liver metastases, and cholangiocarcinomas [56789103031]. Moreover, the PLR has recently been identified as an independent prognostic factor in patients undergoing potentially curative resections for pancreatic and operable colorectal cancers [311]; the PLR is also associated with a poor prognosis in breast cancer patients [32]. The combination of preoperative NLR and PLR has been shown to be significantly associated with the risk of cervical stromal involvement in patients with endometrial cancer [33]. Thus, the preoperative NLR and/or PLR are independent prognostic factors for several malignancies.

Previous studies have demonstrated that neutrophil viability and counts were significantly higher in women than in men because of the effect of sex hormones [14]. Furthermore, another study showed that female patients had higher circulating neutrophil counts, lower lymphocyte counts, and consequently higher NLR, indicating a more immunocompromised state than in male patients during the days immediately following surgery for stomach cancer [15]. Based on these results, we hypothesized that female patients have a higher white blood cell count than male patients under similar circumstances, which is why male patients were excluded in this study.

Liu et al. [34] previously showed that a high preoperative NLR was associated with increased tumor size and a high risk of recurrence in differentiated thyroid cancers. In this study, the NLR did not have significant association with the clinicopathological clinicopathological characteristics in PTC patients. But an elevated PLR values (especially in the first to third quartiles) were associated with an increased risk of lateral LNM (Table 3). However, patients in the fourth quartiles (PLR >156.25) had a lower incidence of lateral LNM than those belonging to the second and third quartiles. Seretis et al. [13] have reported similar results, showing a significant association of between a high NLR and thyroid cancer, especially for NLR >2.5, although the third (NLR >2.5 to 3.0) and fourth (NLR >3 to 6.9) quartiles showed lower incidences of thyroid cancer than the first and second. Although further large multicenter studies are required to confirm this association in thyroid cancer patients, our results suggest that there is a weak association between the NLR or PLR and prognosis in thyroid cancer once the NLR or PLR exceeds a certain value. Previous study showed that combination of NLR and PLR value was found to be much more applicable for predicting postoperative survival than patient stratification according to either the NLR or PLR alone in an esophageal squamous cell carcinoma [18]. Therefore we evaluated the usefulness of combination of NLR and PLR for predicting prognostic factor in patients with PTC. Unfortunately, our result showed no significant correlation with prognostic factors in PTC patients.

There were several limitations to our study. First, our study design was retrospective and only Asian patients in single institution were included; hence, our study did not represent the general population. Second, some studies have reported that chemotherapy can normalize an elevated NLR, and that patients with a normalized NLR may have improved outcomes [3536]. However, our study did not evaluate the changes in NLR and PLR after thyroidectomy, or radioactive iodine therapy. Third, serum CRP levels are not evaluated during routine preoperative laboratory examinations of thyroid cancer patients. Neutrophil and lymphocyte counts may be influenced by infections, inflammation, medication, and other noncancerous conditions [3738]. As we did not evaluate other medical conditions or medications, our results might be influenced by these confounding factors. Fourth, this study included only female patients with PTC.

Despite these limitations, this study offers some insight on our understanding of the link between preoperative inflammatory marker such as NLR, PLR and clinicopathological characteristics in patients with PTC. To the best of our knowledge, this study was the first study for association between PLR and prognostic factors in patients with PTC.

In conclusion, higher preoperative PLR were associated with lateral LNM in patients with PTC. Measurement of the PLR is cost-effective, safe, and readily available. Thus, preoperative PLR may be valuable for predicting adverse clinicopathological outcomes in PTC. More large-scale prospective studies are required to validate our results, before the preoperative NLR or PLR can be used as biomarkers for risk stratification.

Acknowledgements

ACKNOWLEDGMENTS

This work was supported by clinical research grant from Pusan National University Hospital 2015.

Article information

CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.

References

• 1. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009;12:223–226. ArticlePubMed
• 2. Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol 2012;33:749–756. ArticlePubMedPDF
• 3. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010;6:149–163. ArticlePubMed
• 4. Kim S, Cho SW, Min HS, Kim KM, Yeom GJ, Kim EY, et al. The expression of tumor-associated macrophages in papillary thyroid carcinoma. Endocrinol Metab (Seoul) 2013;28:192–198. ArticlePubMedPMC
• 5. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215–220. ArticlePubMedPDF
• 6. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–184. ArticlePubMed
• 7. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007;246:806–814. ArticlePubMed
• 8. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55–60. ArticlePubMed
• 9. Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2008;97:513–518. ArticlePubMed
• 10. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009;58:15–23. ArticlePubMedPDF
• 11. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 2009;197:466–472. ArticlePubMed
• 12. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012;17:216–222. ArticlePubMed
• 13. Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013;205:691–696. ArticlePubMed
• 14. Han SW, Kang SY, Kim SK, Youn HJ, Jung SH. Clinical significance of blood neutrophil-to-lymphocyte ratio in patients with papillary thyroid carcinoma. Korean J Endocr Surg 2014;14:184–189.ArticlePDF
• 15. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, et al. Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci 2007;22(Suppl):S104–S108. ArticlePubMedPMC
• 16. Molloy EJ, O'Neill AJ, Grantham JJ, Sheridan-Pereira M, Fitzpatrick JM, Webb DW, et al. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood 2003;102:2653–2659. ArticlePubMedPDF
• 17. Ito Y, Miyauchi A, Kihara M, Kobayashi K, Miya A. Prognostic values of clinical lymph node metastasis and macroscopic extrathyroid extension in papillary thyroid carcinoma. Endocr J 2014;61:745–750. ArticlePubMed
• 18. Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2013;6:1605–1612. PubMedPMC
• 19. Edge SB. American Joint Committee on Cancer. American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual; 7th ed. New York: Springer; 2010.
• 20. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010;200:197–203. ArticlePubMed
• 21. Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, et al. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer 2013;11:337–341. ArticlePubMed
• 22. McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999;134:1325–1331. ArticlePubMed
• 23. Di Carlo E, Forni G, Musiani P. Neutrophils in the antitumoral immune response. Chem Immunol Allergy 2003;83:182–203. PubMed
• 24. McCourt M, Wang JH, Sookhai S, Redmond HP. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 2001;27:396–403. ArticlePubMed
• 25. Jabłońska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, Jabłonski J. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp (Warsz) 2001;49:63–69. PubMed
• 26. Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 2003;103:335–343. ArticlePubMed
• 27. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 2001;189:197–206. ArticlePubMed
• 28. Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, et al. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 2002;168:5798–5804. ArticlePubMedPDF
• 29. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002;22:913–922. PubMed
• 30. Sharma R, Zucknick M, London R, Kacevska M, Liddle C, Clarke SJ. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer 2008;7:331–337. ArticlePubMed
• 31. Sharma R, Hook J, Kumar M, Gabra H. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 2008;44:251–256. ArticlePubMed
• 32. Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014;110:2524–2530. ArticlePubMedPMCPDF
• 33. Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang HF, et al. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther 2013;6:211–216. PubMedPMC
• 34. Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 2013;107:493–497. ArticlePubMedPDF
• 35. Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010;16:5805–5813. ArticlePubMedPDF
• 36. Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011;104:1288–1295. ArticlePubMedPMCPDF
• 37. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology 2011;11:445–452. ArticlePubMed
• 38. Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2013;111:636–642. ArticlePubMed

Table 1

The Association between Preoperative NLR and PLR Values and the Clinicopathological Characteristics of Papillary Thyroid Cancer

Characteristic	Patients, n (%)	NLR		PLR
		Median (IQR)	P value	Median (IQR)	P value
Age, yr			0.001		<0.001
<45	324 (30.4)	1.75 (1.03-2.31)		135.60 (91.00-163.06)
≥45	742 (69.6)	1.52 (1.16-2.00)		123.60 (99.32-151.42)
Tumor size, cm			0.522		0.021
≤1	774 (75.6)	1.59 (1.20-2.06)		124.41 (103.13-155.09)
>1	292 (27.4)	1.53 (1.22-2.12)		129.17 (106.24-162.44)
T stage			0.370		0.801
1/2	944 (88.6)	1.57 (1.21-2.08)		125.62 (104.05-156.11)
3/4	122 (11.4)	1.63 (1.20-2.13)		127.70 (97.84-156.75)
LNM			0.634		0.765
N0	432 (40.5)	1.57 (1.19-2.07)		125.59 (103.28-156.72)
N1	634 (59.5)	1.68 (1.34-2.24)		132.10 (114.12-149.81)
Multifocality			0.483		0.526
Negative	746 (70)	1.60 (1.23-2.11)		126.06 (105.58-156.75)
Positive	320 (30)	1.53 (1.16-2.04)		126.50 (99.35-154.50)
Hashimoto's thyroiditis			0.005		0.039
Negative	940 (88.2)	1.58 (1.21-2.11)		127.61 (104.89-157.38)
Positive	126 (11.8)	1.52 (1.18-1.89)		119.48 (94.02-147.48)
ETE			0.185		0.805
Negative	654 (61.4)	1.59 (1.20-2.08)		124.31 (103.27-157.95)
Positive	412 (38.6)	1.57 (1.22-2.10)		128.09 (106.15-154.26)
Lateral LNM			0.101		0.316
Negative	1,001 (93.9)	1.57 (1.19-2.07)		125.59 (103.28-156.72)
Positive	65 (6.1)	1.68 (1.34-2.24)		132.10 (114.38-148.46)
LVI			0.155		0.400
Negative	524/715 (73.3)	1.58 (1.21-2.04)		126.96 (103.58-157.59)
Positive	191/715 (26.7)	1.52 (1.13-2.22)		130.18 (104.77-158.92)
BRAF V600E mutation			0.896		0.658
Negative	383/1,003 (38.2)	1.58 (1.17-2.08)		125.96 (101.57-154.28)
Positive	620/1,003 (61.8)	1.57 (1.23-2.10)		125.68 (103.93-156.72)

Statistical significance was tested by the Student t test.

NLR, neutrophil-to-lymphocyte count ratio; PLR, platelet-to-lymphocyte count ratio; IQR, interquartile range; LNM, lymph node metastasis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.

Table 2

Comparisons of the Prevalence of Prognostic Factors between Preoperative NLR Quartile Groups

Variable	Group 1	Group 2	Group 3	Group 4	P value
No. in quartile	266	266	266	268
NLR, range	0.25-1.21	1.21-1.57	1.57-2.07	2.08-10.20
Age, yr	51.99±10.64	50.72±11.09	48.96±11.17a	49.16±11.78a	0.005
BMI, kg/m2	23.55±3.04	23.37±2.96	24.17±13.33	23.30±3.13	0.482
Tumor size, cm	0.86±0.58	0.92±0.61	0.80±0.53	0.88±0.61	0.131
TSH, mIU/L	1.45 (0.92-2.39)	1.38 (0.84-2.26)	1.33 (0.90-2.13)	1.27 (0.84-2.04)	0.245
T stage 3/4, %	31 (11.7)	25 (9.4)	34 (12.8)	32 (11.9)	0.649
LNM, %	166 (62.4)	157 (59.0)	153 (57.5)	158 (59.0)	0.700
Lateral LNM, %	11 (4.1)	20 (7.5)	15 (5.6)	19 (7.1)	0.350
Multifocality, %	90 (33.8)	81 (30.5)	76 (28.6)	73 (27.2)	0.374
ETE, %	101 (38.0)	110 (41.4)	98 (36.8)	103 (38.4)	0.743
LVI, %	57/187 (30.5)	43/171 (25.1)	32/179 (17.9)	59/178 (33.1)	0.006
BRAF V600E mutation, %	147/252 (58.3)	163/248 (65.7)	153/249 (61.4)	157/254 (61.8)	0.405

Values are expressed as mean±SD, median (interquartile range), or number (%). Statistical significance was tested by one-way analysis of variance, or the chi-square test.

NLR, neutrophil-to-lymphocyte count ratio; BMI, body mass index; TSH, thyroid-stimulating hormone; LNM, lymph node metastasis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.

^aThe differences were only between quartile group 1 and quartile group 3 and 4 in post hoc analysis.

Table 3

Comparisons of the Prevalence of Prognostic Factors between Preoperative PLR Quartile Groups

Variable	Group 1	Group 2	Group 3	Group 4	P value
No. in quartile	266	266	266	268
PLR, range	13.32-103.85	104.01-125.96	126.0-155.97	156.25-407.81
Age, yr	52.93±10.62	49.56±11.26a	49.72±11.36a	48.62±11.25a	<0.001
BMI, kg/m2	23.87±3.26	23.51±3.23	23.85±13.27	23.16±2.91	0.631
Tumor size, cm	0.87±0.60	0.86±0.60	0.88±0.59	0.84±0.55	0.914
TSH, mIU/L	1.37 (0.90-2.33)	1.32 (0.78-2.10)	1.42 (0.93-2.24)	1.32 (0.87-2.18)	0.212
T stage 3/4, %	33 (12.4)	24 (9.0)	33 (12.4)	32 (11.9)	0.554
LNM, %	159 (59.8)	154 (57.9)	166 (62.4)	155 (57.8)	0.675
Lateral LNM, %	8 (3.0)	18 (6.8)	25 (9.4)	14 (5.2)	0.018
Multifocality, %	90 (33.8)	70 (26.3)	82 (30.8)	78 (29.1)	0.287
ETE, %	96 (36.1)	100 (37.6)	120 (45.1)	96 (35.8)	0.092
LVI, %	46/177 (26.0)	43/168 (25.6)	52/182 (29.1)	49/188 (26.1)	0.865
BRAF V600E mutation, %	155/254 (61.0)	156/249 (62.7)	152/248 (61.3)	157/252 (62.3)	0.978

Values are expressed as mean±SD, median (interquartile range), or number (%). Statistical significance was tested by one-way analysis of variance, or the chi-square test.

PLR, platelet-to-lymphocyte count ratio; BMI, body mass index; TSH, thyroid-stimulating hormone; LNM, lymph node metastasis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.

^aThe differences were significant only between quartile group 1 and quartile group 2, 3, and 4 in post hoc analysis.

Table 4

Relationships between Clinicopathological Characteristics and the Combination of Preoperative NLR and PLR in Papillary Thyroid Cancer Patients

Characteristic	Score 0	Score 1	Score 2	P value
No. in quartile	334	517	215
NLR	1.23 (0.25-1.87)	1.57 (0.57-5.09)	2.50 (1.88-10.20)
PLR	103.95 (13.32-143.82)	125.43 (47.99-294.70)	181.01 (144.07-407.81)
Age, yr	51.58±11.36	50.09±10.95	48.33±11.47a	0.004
BMI, kg/m2	24.20±11.91	23.34±3.17	23.28±3.07	0.178
Tumor size, cm	0.85±0.57	0.86±0.59	0.88±0.60	0.876
TSH, mIU/L	1.32 (0.79-2.33)	1.43 (0.91-2.24)	1.29 (0.86-2.12)	0.507
T stage 3/4, %	43 (12.9)	52 (10.1)	27 (12.6)	0.383
LNM, %	214 (64.1)	296 (57.3)	124 (57.7)	0.118
Lateral LNM, %	19 (5.7)	34 (6.6)	12 (5.6)	0.817
Multifocality, %	107 (32.0)	153 (29.6)	60 (27.9)	0.563
ETE, %	126 (37.7)	203 (39.3)	83 (38.6)	0.903
LVI, %	65/218 (29.8)	82/343 (23.9)	44/154 (28.6)	0.256
BRAF V600E mutation, %	191/312 (61.2)	305/488 (62.5)	124/203 (61.1)	0.909

Values are expressed as median (interquartile range), mean±SD, or number (%). Statistical significance was tested by one-way analysis of variance, or the chi-square test.

NLR, neutrophil-to-lymphocyte count ratio; PLR, platelet-to-lymphocyte count ratio; BMI, body mass index; TSH, thyroid-stimulating hormone; LNM, lymph node metastasis; ETE, extrathyroidal extension; LVI, lymphovascular invasion.

^aThe differences were significant only between the score 0 and the score 2.

Figure & Data

References

Citations

Citations to this article as recorded by  

• Clinical characteristics and risk analysis of lymph node metastasis in patients with cN0 differentiated thyroid carcinoma
  Meng Wei, Kaipeng Hu, Gaolin Qiu, Qing Lin, Jincan Qian, Yao Lu, Rui Wang
  Scientific Reports.2026;[Epub]     CrossRef
• Feasibility of the Use of Neutrophil to Lymphocyte Ratio (NLR) as an Adjunct to Cytology to Suggest Malignancy: A Prospective Study
  Pankaj Kumar Tiwari, Biju Verghese, KK Arunjeet, Pankaj P. Rao, Dronacharya Routh
  Medical Journal of Dr. D.Y. Patil Vidyapeeth.2026; 19(3): 237.     CrossRef
• Inflammation-based hematologic indices and overall survival in poorly differentiated thyroid carcinoma: a retrospective exploratory study
  Yan Gui, Jiangwei Kong, Xiaohan Liu, Yun Hou, Xudong Wei, Junyi Wang
  Langenbeck's Archives of Surgery.2026;[Epub]     CrossRef
• Preoperative Thyroid Hormone Ratios and Complete Blood Count (CBC)-Derived Biomarkers for Differentiating Benign Thyroid Nodules from Papillary Thyroid Carcinoma: A Retrospective Single-Center Case–Control Study
  Neşe Bülbül, Deniz Gülnihal, Rukiye Çiftçi, Ebru Sena Poyraz, Özgür Eken, Ayşe Fulya Özkanlı, Katja Weiss, Thomas Rosemann, Beat Knechtle
  Journal of Clinical Medicine.2026; 15(15): 5913.     CrossRef
• Integrated Ultrasound Features, Cytologic Subclassification, and Systemic Inflammatory Markers for Predicting Malignancy in Bethesda III Thyroid Nodules
  Emine Yildirim, Pelin Cobanoglu Akbas, Sibel Bektas, Adem Senturk, Pelin Basım, Umut Fırat Turan, Nesimi Mecit, Hanifi Onalan, Hafize Uzun, Mustafa Uygar Kalaycı
  Journal of Clinical Medicine.2026; 15(16): 6375.     CrossRef
• Are Inflammation Markers Derived from Hemogram Parameters Predictive for Papillary Thyroid Carcinoma in Hashimoto’s Thyroiditis Patients?
  Can Akcura, Sedat Can Guney, Samet Alkan, Gamze Gelir Cavdar, Ayca Tan, Hasan Aydede, Zeliha Hekimsoy, Nilufer Ozdemir
  Indian Journal of Surgery.2025; 87(6): 1053.     CrossRef
• Effect of Hemoglobin, Albumin, Lymphocyte Count, and Platelet (HALP) Score on Survival of Patients with Metastatic Thyroid Cancer Treated with Tyrosine Kinase Inhibitors
  Hikmet Öztop, Fazıl Çağrı Hunutlu, Selin İldemir Ekizoğlu, Özen Öz Gül, Soner Cander, Ahmet Bilgehan Şahin
  Journal of Clinical Medicine.2025; 14(4): 1306.     CrossRef
• Nomogram Model for Prognosis of Distant Metastatic DTC Based on Inflammatory and Clinicopathological Factors
  Chenghui Lu, Guoqiang Wang, Zengmei Si, Fengqi Li, Xinfeng Liu, Na Han, Congcong Wang, Jiao Li, Xufu Wang
  Journal of the Endocrine Society.2025;[Epub]     CrossRef
• Utility of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio as an Adjunct in Predicting Malignancy in Thyroid Nodules
  Kul R Singh, Chanchal Rana, Anand Mishra, M Shreyamsa, Pooja Ramakant, V Sasi Mouli
  World Journal of Endocrine Surgery.2025; 16(2): 27.     CrossRef
• Determination of the Predictive Value of Preoperative Hemogram Parameters and BRAF Molecular Test in Predicting Malignancy in Cases with Thyroid Nodules Detected by Bethesda 3 Cytology
  Hasan Berk Şahin, Ugur Kesici, Ozben Yalcin, Seden Atike Arsoy Şahin, Mehmet Guray Duman, Orhan Yalcin
  Indian Journal of Surgical Oncology.2025; 16(6): 1563.     CrossRef
• Correlation Between Preoperative Neutrophil-to-Lymphocyte Ratio and Clinicopathological Characteristics of Papillary Thyroid Carcinomas: Toward a Preoperative Biomarker
  Chaima Ben Ammar, Makram Tbini, Ines Riahi, Mamia Ben Salah
  Ear, Nose & Throat Journal.2025;[Epub]     CrossRef
• Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer
  Zhi-kun Ning, Hao Yi, Tingting Yang, Jiang Liu, Shanshan Su, Ting He, Haoyu Huang, Minghao Xie, Hui Li, Ying Tang, Xiaoping Zhu, Xiang Min
  BMC Cancer.2025;[Epub]     CrossRef
• Correlation between preoperative uric acid levels and lymph node metastases in patients with papillary thyroid cancer: a retrospective study
  ShaoKun Sun, Qin Zhou, Tao Hu
  PeerJ.2025; 13: e19410.     CrossRef
• Clinical Value of Lymphocyte Count in Risk Prediction of Papillary Thyroid Carcinoma: A Case-Control Study in a Chinese Population
  Xiu-Ping Qiu, Ru-Ying Xie, Yang Chen, Mei Tu, Ting Wang
  Journal of Inflammation Research.2025; Volume 18: 12971.     CrossRef
• Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients
  Eren Ozan Yildiz, Kutay Işcen, Feyza Kaya, Onur Alptekin Güney, Suat Can Ulukent
  Medicine.2024; 103(5): e37210.     CrossRef
• The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma
  Yihua Gu, Ming Yu, Jiaqin Deng, Yeqian Lai
  International Journal of General Medicine.2024; Volume 17: 2887.     CrossRef
• Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma
  Junbin Zhang, Jinglin Gong, Hong Liu, Wenwen Zhou, Ming Cai, Chengyao Zhang
  BMC Cancer.2024;[Epub]     CrossRef
• A Machine Learning-Based Model for Preoperative Assessment and Malignancy Prediction in Patients with Atypia of Undetermined Significance Thyroid Nodules
  Gilseong Moon, Jae Hyun Park, Taesic Lee, Jong Ho Yoon
  Journal of Clinical Medicine.2024; 13(24): 7769.     CrossRef
• Preoperative serum inflammation-based scores in medullary thyroid cancer
  Ana Abrantes Figueiredo, Susana Esteves, Margarida Maria Moura, Pedro Marques, Joana Simões-Pereira, Valeriano Leite
  Endocrinología, Diabetes y Nutrición.2023; 70(1): 48.     CrossRef
• Preoperative serum inflammation-based scores in medullary thyroid cancer
  Ana Abrantes Figueiredo, Susana Esteves, Margarida Maria Moura, Pedro Marques, Joana Simões-Pereira, Valeriano Leite
  Endocrinología, Diabetes y Nutrición (English ed.).2023; 70(1): 48.     CrossRef
• Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis
  Elena Russo, Mathilda Guizzardi, Luca Canali, Francesca Gaino, Andrea Costantino, Gherardo Mazziotti, Andrea Lania, Silvia Uccella, Luca Di Tommaso, Fabio Ferreli, Luca Malvezzi, Giuseppe Spriano, Giuseppe Mercante
  Reviews in Endocrine and Metabolic Disorders.2023; 24(6): 1205.     CrossRef
• Association of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio with Clinicopathological Features and Short-Term Outcome in Well-Differentiated Thyroid Cancer
  Sumeet Suresh Malapure, Sibi Oommen, Shivanand Bhushan, Sucharitha Suresh, K. Devaraja
  Indian Journal of Nuclear Medicine.2023; 38(4): 313.     CrossRef
• The predictive value of hematologic parameters in the risk of thyroid malignancy in cases with atypia/follicular lesion of undetermined significance
  Hayri Bostan, Muhammed Erkam Sencar, Murat Calapkulu, Sema Hepsen, Pinar Akhanli, Hakan Duger, Bekir Ucan, Muhammed Kizilgul, Ilknur Ozturk Unsal, Mustafa Ozbek, Erman Cakal
  European Archives of Oto-Rhino-Laryngology.2022; 279(8): 4077.     CrossRef
• Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma
  Canxiao Li, Han Zhang, Shijie Li, Daqi Zhang, Jingting Li, Gianlorenzo Dionigi, Nan Liang, Hui Sun
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Role of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Diagnosing Thyroid Nodule
  Haider Salim Mihson, Ayad Khani Maikhan, Ali Rodan Shuwelif
  Mustansiriya Medical Journal.2022; 21(2): 155.     CrossRef
• Comparison of Mean Platelet Volume, Platelet Distribution Width, Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio and Lymphocyte/Monocyte Ratio in Patients with Differentiated Thyroid Cancer According to TSH Levels
  Seher ÇETİNKAYA ALTUNTAŞ, Ömercan TOPALOĞLU
  Batı Karadeniz Tıp Dergisi.2022; 6(3): 302.     CrossRef
• Delta Neutrophil Index and Neutrophil‐to‐Lymphocyte Ratio in the Differentiation of Thyroid Malignancy and Nodular Goiter
  Mehmet Buğra Bozan, Fatih Mehmet Yazar, İlhami Taner Kale, Mehmet Fatih Yüzbaşıoğlu, Ömer Faruk Boran, Ayşe Azak Bozan
  World Journal of Surgery.2021; 45(2): 507.     CrossRef
• Factors Affecting Central Node Metastasis and Metastatic Lymph Node Ratio in Papillary Thyroid Cancer
  Jungirl Seok, Chang Hwan Ryu, Seog Yun Park, Chang Yoon Lee, Young Ki Lee, Yul Hwangbo, Eun Kyung Lee, You Jin Lee, Tae Sung Kim, Seok‐ki Kim, Yuh‐Seog Jung, Junsun Ryu
  Otolaryngology–Head and Neck Surgery.2021; 165(4): 519.     CrossRef
• Neutrophil to iymphocyte ratio: Does it really differentiate between papillary thyroid carcinomas and multinodular goiter
  Hakan BÖLÜKBAŞI, Serhan YILMAZ
  Ege Tıp Dergisi.2021; 60(1): 63.     CrossRef
• Development and Validation of a Nomogram for Preoperative Prediction of Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma and Type 2 Diabetes Mellitus
  Chao He, Yiqiao Lu, Binqi Wang, Jie He, Haiguang Liu, Xiaohua Zhang
  Cancer Management and Research.2021; Volume 13: 2499.     CrossRef
• The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size
  Taek Yoon Cheong, Sang Duk Hong, Keun-Woo Jung, Yoon Kyoung So, Paula Soares
  PLOS ONE.2021; 16(5): e0251446.     CrossRef
• Usefulness of pre-thyroidectomy neutrophil–lymphocyte, platelet–lymphocyte, and monocyte–lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer
  Cínthia Minatel Riguetto, Icléia Siqueira Barreto, Frederico Fernandes Ribeiro Maia, Lígia Vera Montali da Assumpção, Denise Engelbrecht Zantut-Wittmann
  Clinics.2021; 76: e3022.     CrossRef
• Serum Inflammation-based Scores in Endocrine Tumors
  Pedro Marques, Friso de Vries, Olaf M Dekkers, Márta Korbonits, Nienke R Biermasz, Alberto M Pereira
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): e3796.     CrossRef
• Diferansiye Tiroid Kanserli Hastalarda Preoperatif Nötrofil / Lenfosit Oranının Boyun Ultrasonografisi ve Patolojik Bulgularla İlişkisi
  Mehmet Esat DUYMUŞ
  Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi.2021; 54(2): 243.     CrossRef
• Platelet Activation and Inflammation in Patients with Papillary Thyroid Cancer
  Sorina Martin, Theodor Mustata, Oana Enache, Oana Ion, Andreea Chifulescu, Anca Sirbu, Carmen Barbu, Adrian Miron, Cosmin Giulea, Florin Andrei, Simona Fica
  Diagnostics.2021; 11(11): 1959.     CrossRef
• The prognostic and diagnostic use of hematological parameters in subacute thyroiditis patients
  Murat Calapkulu, Muhammed Erkam Sencar, Davut Sakiz, Hakan Duger, Ilknur Ozturk Unsal, Mustafa Ozbek, Erman Cakal
  Endocrine.2020; 68(1): 138.     CrossRef

• Association of the Preoperative Inflammation-Based Scores with TNM Stage and Recurrence in Patients with Papillary Thyroid Carcinoma: A Retrospective, Multicenter Analysis

  
  Wenjie Chen, Tao Wei, Zhihui Li, Rixiang Gong, Jianyong Lei, Jingqiang Zhu, Tao Huang
  Cancer Management and Research.2020; Volume 12: 1809.     CrossRef
• Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinoma
  Haruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, Chie Masaki, Junko Akaishi, Kiyomi Hames, Chisato Tomoda, Akifumi Suzuki, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Munetaka Masuda, Koichi Ito
  Endocrine.2020; 70(1): 115.     CrossRef
• Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
  Zhenyu Xie, Xin Li, Yuzhen He, Song Wu, Shiyue Wang, Jianjian Sun, Yuchen He, Yu Lun, Jian Zhang
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Hipertiroidi Hastalarında Tedavi Öncesi ve Sonrası Trombosit/Lenfosit ve Nötrofil/Lenfosit Oranlarının Değerlendirilmesi
  Çiğdem CİNDOĞLU, Mehmet GÜLER, Mehmet Ali EREN, Tevfik SABUNCU
  Harran Üniversitesi Tıp Fakültesi Dergisi.2020; 17(1): 104.     CrossRef
• Comparison of Mean Platelet Volume, Platelet Count, Neutrophil/ Lymphocyte Ratio and Platelet/Lymphocyte Ratio in the Euthyroid, Overt Hypothyroid and Subclinical Hyperthyroid Phases of Papillary Thyroid Carcinoma
  Faruk Kutluturk, Serdar S. Gul, Safak Sahin, Turker Tasliyurt
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2019; 19(6): 859.     CrossRef
• The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
  Gilda Varricchi, Stefania Loffredo, Giancarlo Marone, Luca Modestino, Poupak Fallahi, Silvia Martina Ferrari, Amato de Paulis, Alessandro Antonelli, Maria Rosaria Galdiero
  International Journal of Molecular Sciences.2019; 20(16): 3934.     CrossRef
• Different prognostic values of individual hematologic parameters in papillary thyroid cancer due to age-related changes in immunity
  Kwan Ho Lee, Eun Young Seok, Eun Young Kim, Ji Sup Yun, Yong Lai Park, Chan Heun Park
  Annals of Surgical Treatment and Research.2019; 96(2): 70.     CrossRef
• Diagnostic Accuracy of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Detecting Occult Papillary Thyroid Microcarcinomas in Benign Multinodular Goitres
  Dimitrios K. Manatakis, Sophia Tseleni-Balafouta, Lazaros Tzelves, Dimitrios Balalis, Adelais Tzortzopoulou, Dimitrios P. Korkolis, George H. Sakorafas, Emmanouil Gontikakis, Georgios Plataniotis
  Journal of Thyroid Research.2018; 2018: 1.     CrossRef
• Assessment of clinical and pathological features of patients who underwent thyroid surgery: A retrospective clinical study
  Arif Emre, Sami Akbulut, Mehmet Sertkaya, Muharrem Bitiren, Ilhami Taner Kale, Ertan Bulbuloglu, Cemil Colak
  World Journal of Clinical Cases.2018; 6(3): 20.     CrossRef
• Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions
  Nikolaos Machairas, Ioannis D. Kostakis, Anastasia Prodromidou, Paraskevas Stamopoulos, Themistoklis Feretis, Zoe Garoufalia, Christos Damaskos, Gerasimos Tsourouflis, Gregory Kouraklis
  Endocrine Research.2017; 42(4): 311.     CrossRef
• Evaluation of Hemocytometer Parameters as Potential Biomarkers in Benign Multinodular Goiter and Papillary Thyroid Carcinoma
  Erdal Uysal, Seyit Mehmet Ceylan, Efe Sezgin, Hasan Bakir, Ahmet Orhan Gurer, Basar Aksoy, Mehmet Bastemir
  Iranian Red Crescent Medical Journal.2017;[Epub]     CrossRef
• Clinical Value of Blood Neutrophil to Lymphocyte Ratio in Patients with Papillary Thyroid Carcinoma with Neck Lymph Node Metastasis
  Hwa Bin Kim, Hyoung Shin Lee, Sung Won Kim, Seok Won Jeon, Ji Ah Song, Kang Dae Lee
  International Journal of Thyroidology.2017; 10(2): 89.     CrossRef
• Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma
  Dimitrios K. Manatakis, Sofia Tseleni-Balafouta, Dimitrios Balalis, Vasiliki N. Soulou, Dimitrios P. Korkolis, George H. Sakorafas, Georgios Plataniotis, Emmanouil Gontikakis
  International Journal of Endocrinology.2017; 2017: 1.     CrossRef
• Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma
  Ke Jiang, Jianyong Lei, Wenjie Chen, Yanping Gong, Han Luo, Zhihui Li, Rixiang Gong, Jingqiang Zhu
  Medicine.2016; 95(40): e5079.     CrossRef
• Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis
  Ji-Feng Liu, Luo Ba, Hong Lv, Dan Lv, Jin-Tao Du, Xiao-Mei Jing, Ning-Jing Yang, Shao-Xin Wang, Chao Li, Xiao-Xia Li
  Scientific Reports.2016;[Epub]     CrossRef